A urine bladder
tumor antigen test has been developed and is an excellent screening test to rule out bladder cancer.
Not exact matches
More and more men who believe they have low - risk prostate cancers are opting for active surveillance, forgoing treatment and monitoring the cancer closely with prostate - specific
antigen (PSA)
tests, digital rectal exams and ultrasounds at regular intervals to see if their
tumors are growing.
Bryan's group has designed a BiTE against the EGFRvIII
tumor - specific
antigen, which is expressed in a majority of glioblastoma cases, and has performed preclinical
tests to determine its efficacy against EGFRvIII - expressing glioblastoma.
SAN DIEGO, March 28, 2017 (GLOBE NEWSWIRE)-- Invivoscribe ® Technologies Inc., a global company with decades of experience providing internationally standardized clonality and biomarker
testing solutions for the fields of oncology, personalized molecular diagnostics ®, and personalized molecular medicine ®, reports that its next - generation sequencing (NGS) LymphoTrack ® Assay kits are being used by its LabPMM ® clinical laboratories, pharmaceutical partners, and cancer centers to identify and monitor chimeric
antigen receptor T - cells (CAR - T) and engineered T - cell receptors in peripheral blood of subjects in support of immuno - therapeutic drug development and treatment regimen development for both hematologic and solid
tumors.
If an oncologist does a blood
test for prostate cancer, he looks for a
tumor marker called prostate specific
antigen or PSA.